These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9412253)

  • 41. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma.
    Schneider DB; Clary-Macy C; Challa S; Sasse KC; Merrick SH; Hawkins R; Caputo G; Jablons D
    J Thorac Cardiovasc Surg; 2000 Jul; 120(1):128-33. PubMed ID: 10884665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Positron emission tomography (PET) in clinical oncology [Part III]].
    Cabrera Villegas A; García Velloso MJ; Gámez Cenzano C
    Rev Esp Med Nucl; 2002 Jul; 21(4):304-20; quiz 321-3. PubMed ID: 12206748
    [No Abstract]   [Full Text] [Related]  

  • 43. Positron emission tomography.
    Yamamoto YL; Thompson CJ; Diksic M; Meyer E; Feindel WH
    Neurosurg Rev; 1984; 7(4):233-52. PubMed ID: 6152329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.
    Schwartz JM; Stoessel PW; Baxter LR; Martin KM; Phelps ME
    Arch Gen Psychiatry; 1996 Feb; 53(2):109-13. PubMed ID: 8629886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imaging the metabolic footprint of Glut1 deficiency on the brain.
    Pascual JM; Van Heertum RL; Wang D; Engelstad K; De Vivo DC
    Ann Neurol; 2002 Oct; 52(4):458-64. PubMed ID: 12325075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positron Emission Tomography and Single-Photon Emission Computed Tomography in Neurology.
    Miletich RS
    Continuum (Minneap Minn); 2016 Oct; 22(5, Neuroimaging):1636-1654. PubMed ID: 27740992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis of recurrent astrocytoma with fludeoxyglucose F18 PET scanning.
    Mirzaei S; Knoll P; Kohn H
    N Engl J Med; 2001 Jun; 344(26):2030-1. PubMed ID: 11430342
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluating dementia using PET: how do we put into clinical perspective what we know to date?
    Silverman DH; Phelps ME
    J Nucl Med; 2000 Nov; 41(11):1929-32. PubMed ID: 11079506
    [No Abstract]   [Full Text] [Related]  

  • 49. Differentiating cerebral lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
    Hoffman JM; Coleman RE
    AJNR Am J Neuroradiol; 1995 Aug; 16(7):1562-3. PubMed ID: 7484660
    [No Abstract]   [Full Text] [Related]  

  • 50. Brain: positron emission tomography tracers beyond [¹⁸F]fluorodeoxyglucose.
    Singhal T; Alavi A; Kim CK
    PET Clin; 2014 Jul; 9(3):267-76. PubMed ID: 25030390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
    Hooft L; Hoekstra OS; Devillé W; Lips P; Teule GJ; Boers M; van Tulder MW
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3779-86. PubMed ID: 11502811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroscience. A better view of brain disorders.
    Miller G
    Science; 2006 Sep; 313(5792):1376-9. PubMed ID: 16959984
    [No Abstract]   [Full Text] [Related]  

  • 53. [SPECT and PET in neurological practice].
    Steinling M
    Acta Neurol Belg; 1997 Sep; 97(3):163-7. PubMed ID: 9412148
    [No Abstract]   [Full Text] [Related]  

  • 54. Positron Emission Tomography.
    Lameka K; Farwell MD; Ichise M
    Handb Clin Neurol; 2016; 135():209-227. PubMed ID: 27432667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Neurodegenerative disorders and functional imaging: role of astrocytes].
    Magistretti PJ
    Rev Med Suisse Romande; 1997 Sep; 117(9):679-82. PubMed ID: 9411685
    [No Abstract]   [Full Text] [Related]  

  • 56. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder.
    Kwon JS; Kim JJ; Lee DW; Lee JS; Lee DS; Kim MS; Lyoo IK; Cho MJ; Lee MC
    Psychiatry Res; 2003 Jan; 122(1):37-47. PubMed ID: 12589881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective.
    Schirmer M; Calamia KT; Wenger M; Klauser A; Salvarani C; Moncayo R
    Exp Gerontol; 2003 Apr; 38(4):463-70. PubMed ID: 12670633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholangiocarcinoma associated with limbic encephalitis and early cerebral abnormalities detected by 2-deoxy-2-[fluorine-18]fluoro-D-glucose integrated with computed tomography-positron emission tomography: a case report.
    Schmidt SL; Schmidt JJ; Tolentino JC; Ferreira CG; de Almeida SA; Alvarenga RP; Simoes EN; Schmidt GJ; Canedo NH; Chimelli L
    J Med Case Rep; 2016 Jul; 10():200. PubMed ID: 27439460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Meta-analysis on the diagnostic efficacy of FDG-PET].
    Totsuka T
    Kaku Igaku; 2001 Jul; 38(4):363-72. PubMed ID: 11675695
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with.
    Tsuyuguchi N; Matsuoka Y; Sunada I; Matsusaka Y; Haque M
    AJNR Am J Neuroradiol; 2001 Feb; 22(2):311-3. PubMed ID: 11156775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.